MiR‐362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway

Shuya Yang(Air Force Medical University), Kun Yang(Tang Du Hospital)
Cancer Medicine
November 19, 2020
Cited by 36


Related Papers